Houston, TX -- (SBWIRE) -- 02/08/2018 -- According to the procedure, the market for infertility treatment is divided into assisted reproductive technology (ART), artificial insemination (AI), fertilization and other procedures (including egg freezing, sperm freezing and fetal freezing). In 2017, the ART sector accounted for the largest portion of the infertility treatment market due to increased infertility and lifestyle disorders (decreased birth rate), technological innovation in IVF sector, increased adoption, surrogacy by same-sex couples, The same procedure is required. The ART market is further subdivided into IVF and surrogacy. The IVF segment accounts for the largest portion of the ART market. A large part of the IVF segment may be due to the high success rates associated with the procedure and the increased awareness and social acceptability of this method.

For Sample copy of this report: https://www.researchnreports.com/request_sample.php?id=72493

The infertility treatment market is fairly competitive, with a large number of global and local manufacturers of infertility treatment products. The Cooper Companies Inc. (U.S.), Cook Group Incorporated (U.S.), and Thermo Fisher Scientific, Inc. (U.S.) were the top three players in the infertility treatment market in 2017. Product launches, approvals, and product enhancements; agreements, partnerships, and collaborations; and geographic expansions were the major strategies adopted by most of the market players to achieve growth in the infertility treatment market
This report studies infertility treatment market based on procedure, product, patient type, and end user. The report also studies, the factors (such as drivers, restraints, opportunities, and challenges) which affect the market growth in positive and negative manner. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes the micromarkets with respect to their individual growth trends, in the infertility treatment market. The report forecasts the revenue of the market segments with respect to four main regions.
From an insights perspective, this research report has focused on various levels of analysis, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the infertility treatment market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned strategies (market penetration, market development, market diversification, and competitive assessment) for strengthening their market shares. The market is projected to Grow at a CAGR of +10% from 2017 to 2022

Avail Flat 20% Discount on this report: https://www.researchnreports.com/ask_for_discount.php?id=72493

Growth in this market is primarily driven by factors such as the continuous decline in fertility rates; increasing public-private investments, funds, and grants; growing public awareness about infertility and the available treatment options; the rising number of fertility clinics worldwide; and technological advancements in infertility treatment devices are the majors drivers for the growth of the infertility treatment market. On the other hand, the high procedural cost of assisted reproductive techniques in developed markets and unsupportive government regulations for certain infertility treatment options are expected to limit market growth to a certain extent.
For more information: Based on procedure, the infertility treatment market is segmented into assisted reproductive technology (ART), artificial insemination (AI), fertility surgeries, and other procedures. In 2017, the ART segment accounted for the largest share of the infertility treatment market, by procedure, owing to increasing infertility and rising prevalence of lifestyle disorders (leading to decline in the fertility rate), technological innovations in the field of IVF, growing adoption of procedures like surrogacy by same-sex couples, and the high success rate of ART procedures.
On the basis of product, the infertility treatment market is segmented into instruments, media & consumables, and accessories. The instruments segment accounted for the largest share of the infertility treatment market in 2017, whereas the media & consumables segment is expected to grow at the fastest CAGR during the forecast period.

On the basis of end user, the market is segmented into fertility centers, hospitals & clinics, research institutes, and cryobanks. The fertility centers segment accounted for the largest share of the infertility treatment market in 2017. The increasing number of fertility centers across the globe, the high success rates in fertility centers, and increasing medical tourism are the key factors driving market growth in this segment.